Clinical Aspects of the Temporal Arteritis. The intense headache, temporal tumefaction, mandibular claudication and visual loss are the main signals and symptoms. There may occur dysacusis, necrosis of the tongue and odynophagia. A better understanding of this disease will lead to the increment of cure possibilities and reduction of morbidity in the patients, especially in ophthalmologic and otorhinolaryngologic areas. Its clinical manifestations depend upon the location of the relative or absolute ischemia of the territories irrigated by the affected vessels 3.
|Published (Last):||5 June 2012|
|PDF File Size:||13.12 Mb|
|ePub File Size:||10.68 Mb|
|Price:||Free* [*Free Regsitration Required]|
Clinical Aspects of the Temporal Arteritis. The intense headache, temporal tumefaction, mandibular claudication and visual loss are the main signals and symptoms. There may occur dysacusis, necrosis of the tongue and odynophagia. A better understanding of this disease will lead to the increment of cure possibilities and reduction of morbidity in the patients, especially in ophthalmologic and otorhinolaryngologic areas.
Its clinical manifestations depend upon the location of the relative or absolute ischemia of the territories irrigated by the affected vessels 3. Clinically, most cases have an insidious beginning, which explains the delay until the diagnosis that many times is observed in this disease 5. The vision loss for ischemic optical neuropathy is the most feared complication, in addition to cerebral infarct and aortic aneurysm. In the otorhinolaryngologic focus, there may occur neurosensorial hearing loss and lingual necrosis 4 6.
The diagnosis is eminently clinical and laboratorial, with histopathological confirmation, and its treatment is made with long-term corticotherapy 7. The mortality for temporal arteritis results mainly from secondary factors and seldom from direct factors, with the aortic rupture.
However both mortality and morbidity associated to such vasculitis are higher and higher, specially due to its clinical manifestations, the age of the population affected and the relative therapeutic aggressivity. Because it is a multisystemic disease of late diagnosis and growing morbimortality, the accomplishment of a literature review is necessary whose objective is to clarify its clinical signs and symptoms, as well and confirm its otorhinolaryngologic manifestations both before the poorly broadcast knowledge of this disease and its relevance.
METHOD The review was made by means of researches on online databases, which provided articles and information for the production of such bibliographic review, and the sources and references to be accessed at any time for research and improvement, taking into account the scientific literature is constantly being renewed. It was Initially described in by Hutchinson, who observed it in the shape of a very painful inflammation of the temporal artery in an year-old patient.
Some years after, Horton and collaborators made the clinical and histopathological correlations of the disease and named it temporal arteritis. In , both mono and binocular vision loss was registered for the first time as a complication in the affected patients.
In , Paulley e Hughes described many forms of the disease. Since then, more varied types of clinical manifestations, prognostics and complications were observed 2. Women have from 2 to 6 times more chances to be affected than men 1 , probably due to hormonal factors; however we observed that the female sex prevalence is associated with the rheumatic polymialgia and not in its pure form 5.
The percentage is also higher in persons with a history of smoking. Etiopathogenesis Until today the etiopathogenesis has not been fully clarified. So we can say the more elastic tissue there is in the artery, the greater the probability to develop Giant Cells Arteritis 7, 8. The inflammatory process typical of giant cells arteritis is generally superposed to the arteriosclerotic changes found in adults and old-aged.
The inflammatory lesions are generally distributed in a sparse and uneven manner along the course of the affected vessels. Mostly important among all changes is the granulomatous inflammatory process in several focuses with the presence of lymphocytic, histiocytes and epitheliod cells along the elastic lamina and involving the medium and adventitious layers.
Multinuclear giant cells are commonly seen in the vicinity of degenerated muscular cells or sometimes close to the elastic fragmented cell. The adventitious layer inflammation is prominent 8, 9.
The involvement of nerves and nervous terminations on the artery wall and surface is what causes spontaneous pain and the artery pulsation 9. Signs and Symptoms Generally the constitutional symptoms precede the headache, polymialgia and ocular and neurological manifestations. The systemic symptoms include fever, adynamia, inapetency, weight loss and unspecific myalgias, mainly in the morning, with rigidity of the neck and the musculature of the pelvic and shoulder girdle 8, 9 , as well as night sudoresis and anorexia 5.
The rheumatic polymialgia with pain and hardening of the neck, dorsum, pelvic and shoulder girdle, as well as the upper and lower ends proximal muscles is common in the GCA. The claudication during the walk may also be observed 9. The patient feels pain when he chaws or talk longer and improves with rest and it occurs in cases where there is facial artery involvement.
The tongue and deglutition muscles claudication and chewing muscles spasms, named as lockjaw may also occur 8, 9. Other causes for vision loss in GCA include posterior or retrobulbar ischemic optic neuropathy, much less frequent than NAION, ischemic ocular syndrome and obstruction of the central artery of the retina or its branches.
Ischemia of the anterior segment of the eye with keratopathy, chemosis, scleritis and episcleritis and unevenness of the pupil shape may also occur. Later findings include cataract, secondary glaucoma, rubeosis iridis and nonreactive pupils 8, 9.
Campimetric defects and cortical blindness, resulting from the vertebral, carotid and hypofisary arteries involvement have also been reported 9. Ophthalmoplegia is a frequent manifestation of the GCA and, sometimes, when the tropy measures only a few dioptres, the patients complain of diplopia without the ophthalmoparesis to be detected in the clinical exam.
The contrary, that is, ophthalmoplegia without diplopia, is very common, and it occurs when the vision is significantly reduced. The ophthalmoplegia may precede other more common manifestations of the disease 9. Anisocoria occurs rarely in the GCA, since the ciliary ganglion is rich in anastomoses. However the mydriasis associated with ophthalmoplegia has been reported. Such headache is from a short time ago, about 15 days to 1 month and is different from other headaches the patient could have had before.
Some report pain in any part of the head or diffusely as in the muscular contraction headache 9. In addition, it may present with a number of other manifestations, such as, depression, mental confusion, dementia, psychosis; infarct or cerebral hemorrhage, transient ischemic episodes; ataxia, trembling, deafness, tinnitus, vertigo manifestations relating to the facial artery ; facial paralysis, syncope, convulsions, meningism, insipid diabetes; transverse myelopathy and peripheral neuropathies 8.
In this case, the visual loss for anterior ischemic optic neuropathy may be the first manifestation. The main otorhinolaryngologic manifestations are dry persistent cough, odinophagy, dysphonia, lingual paresthesia and claudication, buzz, glossitis, lingual ischemia and necrosis and neurosensorial dysacusis, which may range from slight to deafness in case the treatment is not duly performed 3, 7, 11 12, Diagnosis The Giant Cells Arteritis diagnosis is mostly clinical.
By this format, a patient is deemed to be a carrier of GCA if, at least, three of the five criteria are met. The presence of three or more of these five criteria is associated to a sensitivity of In the initial phase, the exam may reveal only subtle changes such as soreness upon the artery palpation. The area adjacent to the vessel may be edemaciated. Generally upon palpation the artery becomes thick, hard and nodular and the soreness expands to the circumjacent region. The pulse is commonly diminished or absent in the advanced phases.
The retinal examination is normal in an individual with full vision. In cases of ischemic optic neuropathy, in the acute phase, the papilla is edemaciated and with small hemorrhages.
In the chronic phase, such changes are replaced for paleness and atrophy 5. The visual loss is an important finding. The visual loss generally results from the anterior ischemic optic neuropathy.
Thus, we should suspect of GCA in patients above 50 years old with this ophthalmologic condition diagnosis, and start the corticotherapy even with normal ESR The reactive protein C is also elevated in the GCA. Other possible laboratorial changes include: Slight normocytic normochromic anemia; discreet leucocytosis; liver function abnormalities, more commonly discreet increases of the of alkaline phosphatase and transaminases; elevation of the plasma fibrinogen levels; alpha-2 globulin, complement and gamma-globulin and albumin reduction 5.
The temporal artery biopsy must be carried out in all patients for whom there is suspicion of GCA based on the anamnesis and physical exam, even if the ESR had been normal 5. We must perform temporal artery unilateral biopsy and keep on with the treatment when the biopsy is positive. When the biopsy is negative, but the clinical suspicion is high, we should perform contralateral biopsy.
In the patients with intermediate clinical suspicion we should request temporal artery biopsy and ESR. This group is composed by patients with any of the criteria of major specificity or with anterior ischemic optic neuropathy. Moreover, any of the following findings represent an intermediate clinical suspicion: High ESR, recent beginning headache in old-aged patient, or clinical changes of the temporal artery.
If both temporal arteries biopsy is negative, other reasons for ESR increase must be researched infectious diseases, neoplasms, diabetes or conjunctive tissue diseases, for example. In patients with normal ESR and temporal artery unilateral biopsy without changes, the GCA diagnosis is not much probable.
The microscopic exam reveals a panarteritis with perivascular inflammatory infiltrate, intimate hypertrophy, medium necrosis associated with granulomatous tissue formation, presence of giant cells and light thrombosis. There is interposition of healthy and other committed areas. Biopsies obtained in initial phases normally reveal a prevalence of inflammatory infiltrate, while in the more advanced phases, we observe more easily the formation of granuloma and giant cells.
In the context of temporal arteritis, the peripheral nervous system involvement is not much frequent 3. Therefore, to achieve the giant cells arteritis diagnosis, we must try and make blood tests, biopsy, ophthalmologic exam, angiography, ultrasonography and thyroid function.
The differential diagnosis includes dental problems, trigeminal neuralgia, sinusitis, otitis, blood vessels or ocular muscles alterations, among many other causes of headache Treatment The treatment of patients with temporal arteritis is crucial to avoid vision loss and the therapy should be started based on the clinical suspicion, and not on the biopsy results We use one type of corticosteroid, prednison.
Typically, the treatment begins with mg orally everyday in adults 16 , and may reach mg per day Another drug that may also be used is metylprednisolon 2. The main objective of the corticotherapy is the prevention of blindness, mainly when one of the eyes has already been affected, or of other severe complications of the disease. Once the steroid dosage is defined, it must be maintained until the symptoms have disappeared and the erythrocyte sedimentation rate is back to normal Therefore, inflammatory reaction proofs must be monitored, such as the VSG decrease and C reactive protein.
The GCA has a self-limited course that generally lasts for one to two years, but may last from months to 14 years and the use of corticoids must be suspended between 6 months and 2 years. Special attention and care should be given to their use, because they may cause or aggravate osteoporosis, psychosis and digestive hemorrhage However the disease progression is not uncommon with the occurrence of anterior ischemic optic neuropathy NAION in the second eye of a patient receiving conventional dosages of corticosteroids Another medications category that may be implemented is that of immunosuppressors, which suppress key-factors involved in the immunologic reaction; the two choice drugs are azathioprine and methotrexate 1.
Some have been suggesting the use of aspirin or anticoagulants in the treatment of the temporal arteritis to prevent ischemic lesions, due to reports of thrombocytosis in some patients The patients survival is not different from the general population in the same age range With the treatment, most individuals achieve complete remission; however, the vision loss may be irreversible If the aorta artery or some of its affluent vessels are involved, the prognosis may be worse, because such vessels may enlarge and even break up.
However, most complications relating to giant cells arteritis are caused more by the therapy with steroid hormones than by the disease itself Several autoimmune mechanisms are related and they cause the arterial inflammatory process.
A stronger knowledge about the beginning, development and diagnosis of the temporal arteritis will contribute for the treatment evolution and possibility of more satisfactory prognoses. Predictors of recurrent ischemic optic neuropathy in giant cell arteritis.
J Neuroophthalmol. Temporal Giant Cell Arteritis. The Medscape Journal.
Arterite de células gigantes
Vision loss or double vision, particularly in people who also have jaw pain Sudden, permanent loss of vision in one eye Pain and stiffness in the neck, shoulders or hips are common symptoms of a related disorder, polymyalgia rheumatica. About 50 percent of people with giant cell arteritis also have polymyalgia rheumatica. When to see a doctor If you develop a new, persistent headache or any of the signs and symptoms listed above, see your doctor without delay. Request an Appointment at Mayo Clinic Causes With giant cell arteritis, the lining of arteries becomes inflamed, causing them to swell. Almost any large or medium-sized artery can be affected, but swelling most often occurs in the arteries in the temples. These are just in front of your ears and continue up into your scalp. Certain genes and environmental factors might increase your susceptibility to the condition.
Qu'est-ce que la maladie de Horton ou artérite temporale ?
C-reactive protein , another inflammatory marker, may be elevated. Platelets may also be elevated. Biopsy[ edit ] Histopathology of giant cell vasculitis in a cerebral artery. The gold standard for diagnosing temporal arteritis is biopsy , which involves removing a small part of the vessel under local anesthesia and examining it microscopically for giant cells infiltrating the tissue. Unilateral biopsy of a 1. Recent studies have shown that 3T MRI using super high resolution imaging and contrast injection can non-invasively diagnose this disorder with high specificity and sensitivity.
Artérite temporale: Symptômes, Prévention, Traitement